scholarly journals A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease

2015 ◽  
Vol 45 ◽  
pp. 1159-1166 ◽  
Author(s):  
Nuriye Nuray ULUSU ◽  
Gökhan YILMAZ ◽  
Zübeyde ERBAYRAKTAR ◽  
Ahmet Turan EVLİCE ◽  
Sevgi ARAS ◽  
...  
1979 ◽  
Vol 18 (06) ◽  
pp. 278-282 ◽  
Author(s):  
Matina Kesse-Elias ◽  
D. Koutras ◽  
P. Pandos ◽  
S. Papazoglou ◽  
S. Moulopoulos ◽  
...  

SummarySerum vitamin B12 and folic acid levels were measured in 48 hyperthyroid patients and in a group of euthyroid controls. The levels of vitamin B12 ranged from 120-900 pg/ml with a mean of 429.3 ± 30.9 pg/ml (SE). The mean serum vitamin B ? level was lower in hyperthyroid patients than in normal controls, the difference being statistically significant (t = 2.584, p < 0.025). Serum vitamin B12 levels showed a statistically significant negative correlation with the clinical index of Grooks et al. (r = 0.344, p < 0.05). The findings, although not excluding the involvement of auto-immune gastritis in patients with low serum vitamin B12 levels, suggest a direct action of increased thyroid hormone concentrations. Serum folic acid levels ranged from 0.5- 13.8 ng/ml with a mean of 6.8 ± 0.46 ng/ml (SE). The mean serum folic acid levels were higher in the hyperthyroid patients than in normal controls but the difference was not statistically significant (t = 1.2, p > 0.2). The serum folic acid levels did not show any statistically significant correlation with the clinical index of Grooks et al. The fact that no statistically significant difference was found between the mean value in hyperthyroid patients and the mean value in normal controls is probably due to the high folic acid intake in Greece.


Nature ◽  
1956 ◽  
Vol 178 (4546) ◽  
pp. 1347-1348 ◽  
Author(s):  
M. S. NARAYANAN ◽  
K. G. SHENOY ◽  
G. B. RAMASARMA

2018 ◽  
Vol 24 (3) ◽  
pp. 119
Author(s):  
Emrah Turhan ◽  
Fusun G Varol ◽  
Hakan Gurkan ◽  
Cenk N. Sayin

<p><strong>Objective:</strong> The underlying gene-environment interaction of fetal neural tube defects is affected by several factors including geography, ethnicity and time. Local features of fetal neural tube defects were described.<br /><strong></strong></p><p><strong>Study Design:</strong> A prospective cohort study of 48 fetal neural tube defects in a single tertiary medical center at the northwestern region of Turkey (2013-2015) was done via ultrasound, magnetic resonance imaging (MRI), conventional karyotyping, maternal methylenetetrahydrofolate reductase c.677C&gt;T (rs1801133) single-nucleotide polymorphism and maternal serum levels of folic acid, vitamin B12 and zinc. For comparison of means, a Student’s T-Test was used.</p><p><strong>Results:</strong> The prevalence of neural tube defects was 11.4 per 10000 births (48/42000) in northwestern Turkey. The defects on the cranium (n=23; 47.9%) and spine (n=25; 52.1%) were ultrasonographically detected. MRI did not give additional benefit over the ultrasonography. The ratio of associated anomalies in neural tube defect group was 25%. Two fetal neural tube defects with Down syndrome were remarkable. The rate of homozygous methylenetetrahydrofolate reductase c.677C &gt; T SNPs among the mothers of neural tube defect fetuses (n=20) was 15%. Comparing with gestationally matched healthy pregnancies, although maternal BMIs and periconceptional folate intake of neural tube defect group were significantly different, maternal serum folic acid, vitamin B12 and zinc levels were similar.</p><p><strong>Conclusion:</strong> The northwestern region appeared to be a relatively low prevalence area of Turkey for fetal neural tube defects. Any association with maternal serum folic acid, vitamin B12 and zinc levels could not be shown in this region.</p>


BMJ ◽  
1966 ◽  
Vol 1 (5493) ◽  
pp. 955-957 ◽  
Author(s):  
J. S. Malpas ◽  
G. H. Spray ◽  
L. J. Witts

Sign in / Sign up

Export Citation Format

Share Document